Astoriom forges strategic alliance with Carolina Molecular to streamline biospecimen workflows
Research Triangle Park, North Carolina, United States, has witnessed a significant consolidation of molecular testing and biospecimen storage services as Astoriom and Carolina Molecular announce a strategic partnership designed to address critical workflow challenges in clinical research operations.
The collaboration merges Carolina Molecular’s 25-year track record in CAP/CLIA-certified molecular testing with Astoriom’s global network of ICH-compliant stability storage and biorepository facilities spanning the United States, European Union, and United Kingdom.
Enhanced capabilities across research pipeline
Carolina Molecular brings sophisticated NGS Foundry services and bioinformatics analysis capabilities to the partnership, whilst Astoriom contributes extensive expertise in ultra-low temperature storage solutions and CAP-certified biorepository operations. The integrated approach eliminates traditional logistical bottlenecks between sample storage and molecular analysis phases.
“We’re thrilled to partner with Astoriom to deliver a fully integrated solution for our clients,” said Trent Carrier, President of Carolina Molecular. “By combining our cutting-edge molecular testing with Astoriom’s world-class storage capabilities, we’re streamlining logistics and providing an end-to-end solution at a time when operational efficiency is more critical than ever.”
Addressing operational challenges
The partnership specifically targets Contract Research Organisations, pharmaceutical companies, and biotechnology firms requiring seamless sample management throughout the research and development lifecycle. By establishing unified workflows from sample receipt through advanced molecular analysis, the collaboration addresses longstanding operational inefficiencies.
“At Astoriom, we believe the most effective way to support innovation is by working together across the research and development ecosystem,” said Lori A. Ball, CEO, Astoriom. “Our collaboration with Carolina Molecular is a great example of that approach; their testing expertise and our trusted biorepository and stability storage capabilities create seamless solutions for customers.”
The alliance emphasises regulatory compliance maintenance whilst accelerating research timelines through coordinated sample management protocols.
For more information, visit: https://www.astoriom.com/our-solutions
Lori A. Ball, CEO, Astoriom
